Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators.

Senore C, Giovo I, Ribaldone DG, Ciancio A, Cassoni P, Arrigoni A, Fracchia M, Silvani M, Segnan N, Saracco GM.

Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31428-8. doi: 10.1016/j.ejso.2018.09.009. [Epub ahead of print]

PMID:
30343994
2.

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.

Mellai M, Cattaneo M, Storaci AM, Annovazzi L, Cassoni P, Melcarne A, De Blasio P, Schiffer D, Biunno I.

Oncotarget. 2018 Aug 24;9(66):32731. doi: 10.18632/oncotarget.26066. eCollection 2018 Aug 24.

3.

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.

Schiffer D, Mellai M, Boldorini R, Bisogno I, Grifoni S, Corona C, Bertero L, Cassoni P, Casalone C, Annovazzi L.

Int J Mol Sci. 2018 Sep 12;19(9). pii: E2724. doi: 10.3390/ijms19092724. Review.

4.

Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.

Franco P, De Bari B, Arcadipane F, Lepinoy A, Ceccarelli M, Furfaro G, Mistrangelo M, Cassoni P, Valgiusti M, Passardi A, Casadei Gardini A, Trino E, Martini S, Iorio GC, Evangelista A, Ricardi U, Créhange G.

Radiat Oncol. 2018 Sep 10;13(1):172. doi: 10.1186/s13014-018-1124-9.

5.

Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.

Bertero L, Anfossi V, Osella-Abate S, Disanto MG, Mantovani C, Zenga F, Rudà R, Garbossa D, Soffietti R, Ricardi U, Papotti M, Cassoni P.

PLoS One. 2018 Sep 5;13(9):e0203570. doi: 10.1371/journal.pone.0203570. eCollection 2018.

6.

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.

Marchiò C, Dell'Orto P, Annaratone L, Geyer FC, Venesio T, Berrino E, Verdun di Cantogno L, Garofoli A, Rangel N, Casorzo L, dell'Aglio C, Gugliotta P, Trisolini E, Beano A, Pietribiasi F, Orlassino R, Cassoni P, Pich A, Montemurro F, Mottolese M, Vincent-Salomon A, Penault-Llorca F, Medico E, Ng CKY, Viale G, Sapino A.

Am J Surg Pathol. 2018 Sep;42(9):1190-1200. doi: 10.1097/PAS.0000000000001100.

7.

FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.

Rangel N, Fortunati N, Osella-Abate S, Annaratone L, Isella C, Catalano MG, Rinella L, Metovic J, Boldorini R, Balmativola D, Ferrando P, Marano F, Cassoni P, Sapino A, Castellano I.

BMC Cancer. 2018 Jul 3;18(1):703. doi: 10.1186/s12885-018-4624-y.

8.

Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation.

Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Trino E, Cassoni P, Arena V, Baccega M, Racca P, Faletti R, Rondi N, Morino M, Ricardi U.

Cancer Invest. 2018;36(5):279-288. doi: 10.1080/07357907.2018.1479413. Epub 2018 Jun 28.

PMID:
29953269
9.

Safe transportation of formalin-fixed liquid-free pathology specimens.

Metovic J, Bertero L, Musuraca C, Veneziano F, Annaratone L, Mariani S, Cassoni P, Bussolati G, Papotti M.

Virchows Arch. 2018 Jul;473(1):105-113. doi: 10.1007/s00428-018-2383-4. Epub 2018 Jun 2.

PMID:
29860620
10.

The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review.

Monticelli M, Zeppa P, Zenga F, Altieri R, Mammi M, Bertero L, Castellano I, Cassoni P, Melcarne A, La Rocca G, Sabatino G, Ducati A, Garbossa D.

Clin Neurol Neurosurg. 2018 Jul;170:120-126. doi: 10.1016/j.clineuro.2018.05.015. Review.

PMID:
29777944
11.

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.

Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A.

Radiat Oncol. 2018 May 2;13(1):83. doi: 10.1186/s13014-018-1035-9.

12.

Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices.

Mariani S, Bertero L, Coppola V, Saracco G, Arezzo A, Francia Di Celle P, Metovic J, Marchiò C, Cassoni P.

Expert Rev Mol Diagn. 2018 May;18(5):467-475. doi: 10.1080/14737159.2018.1468254. Epub 2018 Apr 26.

PMID:
29676606
13.

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Corso S, Cargnelutti M, Durando S, Menegon S, Apicella M, Migliore C, Capeloa T, Ughetto S, Isella C, Medico E, Bertotti A, Sassi F, Sarotto I, Casorzo L, Pisacane A, Mangioni M, Sottile A, Degiuli M, Fumagalli U, Sgroi G, Molfino S, De Manzoni G, Rosati R, De Simone M, Marrelli D, Saragoni L, Rausei S, Pallabazzer G, Roviello F, Cassoni P, Sapino A, Bass A, Giordano S.

Neoplasia. 2018 May;20(5):443-455. doi: 10.1016/j.neo.2018.02.003. Epub 2018 Mar 23.

14.

Double cystic brain metastasis in a patient with stable pancreatic intraductal papillary mucinous neoplasm.

Tardivo V, Vincitorio F, Monticelli M, Bertero L, Zenga F, Ducati A, Cassoni P, Garbossa D.

Br J Neurosurg. 2018 Mar 20:1-5. doi: 10.1080/02688697.2018.1451824. [Epub ahead of print]

PMID:
29557198
15.

RON tyrosine kinase mutations in brain metastases from lung cancer.

Milan M, Benvenuti S, Balderacchi AM, Virzì AR, Gentile A, Senetta R, Cassoni P, Comoglio PM, Stella GM.

ERJ Open Res. 2018 Mar 6;4(1). pii: 00083-2017. doi: 10.1183/23120541.00083-2017. eCollection 2018 Jan.

16.

Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function.

Antognelli C, Trapani E, Delle Monache S, Perrelli A, Fornelli C, Retta F, Cassoni P, Talesa VN, Retta SF.

Data Brief. 2017 Dec 13;16:929-938. doi: 10.1016/j.dib.2017.12.026. eCollection 2018 Feb.

17.

The role of the AR/ER ratio in ER-positive breast cancer patients.

Rangel N, Rondon-Lagos M, Annaratone L, Osella-Abate S, Metovic J, Mano MP, Bertero L, Cassoni P, Sapino A, Castellano I.

Endocr Relat Cancer. 2018 Mar;25(3):163-172. doi: 10.1530/ERC-17-0417.

PMID:
29386247
18.

A 68-Year-Old Woman with A Left Orbital and Temporal Mass.

Bertero L, Zenga F, Maletta F, Senetta R, Cassoni P.

Brain Pathol. 2018 Jan;28(1):133-134. doi: 10.1111/bpa.12580. No abstract available.

PMID:
29265635
19.

Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Bertero L, Massa F, Metovic J, Zanetti R, Castellano I, Ricardi U, Papotti M, Cassoni P.

Virchows Arch. 2018 Apr;472(4):519-531. doi: 10.1007/s00428-017-2276-y. Epub 2017 Dec 5. Review.

PMID:
29209757
20.

Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma.

Valentini MC, Mellai M, Annovazzi L, Melcarne A, Denysenko T, Cassoni P, Casalone C, Maurella C, Grifoni S, Fania P, Cistaro A, Schiffer D.

Oncotarget. 2017 Oct 4;8(53):91636-91653. doi: 10.18632/oncotarget.21482. eCollection 2017 Oct 31.

21.

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.

Antognelli C, Trapani E, Delle Monache S, Perrelli A, Daga M, Pizzimenti S, Barrera G, Cassoni P, Angelucci A, Trabalzini L, Talesa VN, Goitre L, Retta SF.

Free Radic Biol Med. 2018 Feb 1;115:202-218. doi: 10.1016/j.freeradbiomed.2017.11.014. Epub 2017 Nov 21.

22.

Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Zugna D, Senetta R, Osella-Abate S, Fierro MT, Pisacane A, Zaccagna A, Sapino A, Bataille V, Maurichi A, Picciotto F, Cassoni P, Quaglino P, Ribero S.

Br J Cancer. 2018 Feb 6;118(3):398-404. doi: 10.1038/bjc.2017.397. Epub 2017 Nov 9.

PMID:
29123256
23.

Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.

Conti L, Vatrano S, Bertero L, Masu L, Pacchioni D, Daniele L, De Rosa G, Cassoni P, Volante M, Papotti M.

Hum Pathol. 2017 Nov;69:23-30. doi: 10.1016/j.humpath.2017.09.004. Epub 2017 Sep 27.

PMID:
28962946
24.

Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study.

Ribero S, Podlipnik S, Osella-Abate S, Sportoletti-Baduel E, Manubens E, Barreiro A, Caliendo V, Chavez-Bourgeois M, Carrera C, Cassoni P, Malvehy J, Fierro MT, Puig S.

Eur J Cancer. 2017 Nov;85:59-66. doi: 10.1016/j.ejca.2017.07.051. Epub 2017 Sep 8.

PMID:
28888850
25.

Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.

Arcadipane F, Franco P, Ceccarelli M, Furfaro G, Rondi N, Trino E, Martini S, Iorio GC, Mistrangelo M, Cassoni P, Racca P, Morino M, Ricardi U.

Asia Pac J Clin Oncol. 2018 Jun;14(3):217-223. doi: 10.1111/ajco.12768. Epub 2017 Aug 30.

PMID:
28856848
26.

The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.

Castellano I, Metovic J, Balmativola D, Annaratone L, Rangel N, Vissio E, Arisio R, Macrì L, Pecchioni C, Sarotto I, Montarolo F, Muscarà F, Marchiò C, Cassoni P, Kulka J, Sapino A.

PLoS One. 2017 Aug 14;12(8):e0182073. doi: 10.1371/journal.pone.0182073. eCollection 2017.

27.

Distinctive pathological and clinical features of lung carcinoids with high proliferation index.

Marchiò C, Gatti G, Massa F, Bertero L, Filosso P, Pelosi G, Cassoni P, Volante M, Papotti M.

Virchows Arch. 2017 Dec;471(6):713-720. doi: 10.1007/s00428-017-2177-0. Epub 2017 Jun 19.

28.

Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.

Mariani S, Bertero L, Osella-Abate S, Di Bello C, Francia di Celle P, Coppola V, Sapino A, Cassoni P, Marchiò C.

Br J Cancer. 2017 Jul 25;117(3):358-366. doi: 10.1038/bjc.2017.170. Epub 2017 Jun 15.

29.

Androgen receptor status predicts development of brain metastases in ovarian cancers.

Mittica G, Senetta R, Scotto G, Aglietta M, Maggiorotto F, Ghisoni E, Genta S, Boldorini R, Manini C, Morra I, Buosi R, Sapino A, Cassoni P, Valabrega G.

Oncotarget. 2017 Jun 20;8(25):41143-41153. doi: 10.18632/oncotarget.17068.

30.

Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma.

Ruggieri S, Tamma R, Resta N, Albano F, Coccaro N, Loconte D, Annese T, Errede M, Specchia G, Senetta R, Cassoni P, Ribatti D, Nico B.

Oncotarget. 2017 May 9;8(19):31254-31269. doi: 10.18632/oncotarget.16115.

31.

Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Racca P, Morino M, Numico G, Ricardi U.

Expert Rev Anticancer Ther. 2017 Apr;17(4):335-345. doi: 10.1080/14737140.2017.1288104. Epub 2017 Feb 17. Review.

PMID:
28277103
32.

Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas.

Duregon E, Senetta R, Bertero L, Bussolati B, Annaratone L, Pittaro A, Papotti M, Marchiò C, Cassoni P.

Tumour Biol. 2017 Feb;39(2):1010428317694311. doi: 10.1177/1010428317694311.

PMID:
28229621
33.

Prognostic role of maspin expression in melanoma: probably far from clinical use.

Ribero S, Senetta R, Osella-Abate S, Scalzo MS, Castellano I, Lentini F, Baboi AP, Fierro MT, Sapino A, Cassoni P.

Histopathology. 2017 Jul;71(1):158-162. doi: 10.1111/his.13188. Epub 2017 Apr 3. No abstract available.

PMID:
28211082
34.

No evidence of association of human polyomaviruses V6, V7 and V12, and Saint Louis human polyomavirus with squamous cell carcinoma.

Ribero S, Costa C, Sidoti F, Osella-Abate S, Senetta R, Cassoni P, Fierro MT, Cavallo R.

Br J Dermatol. 2017 Oct;177(4):e112-e113. doi: 10.1111/bjd.15388. Epub 2017 Sep 4. No abstract available.

PMID:
28207925
35.

Eosinophilia - associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel disease.

Canavese G, Villanacci V, Antonelli E, Cadei M, Sapino A, Rocca R, Daperno M, Suriani R, Di Santo MG, Cassoni P, Bernardini N, Bassotti G.

APMIS. 2017 Mar;125(3):179-183. doi: 10.1111/apm.12639. Epub 2017 Jan 25.

PMID:
28120414
36.

The RNA-binding protein ESRP1 promotes human colorectal cancer progression.

Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfò I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F.

Oncotarget. 2017 Feb 7;8(6):10007-10024. doi: 10.18632/oncotarget.14318.

37.

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

Marchiò C, Mariani S, Bertero L, Di Bello C, Francia Di Celle P, Papotti M, Rudà R, Soffietti R, Cassoni P.

Neuro Oncol. 2017 Mar 1;19(3):451-453. doi: 10.1093/neuonc/now244. No abstract available.

38.

Erratum: Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling.

Avanzato D, Genova T, Fiorio Pla A, Bernardini M, Bianco S, Bussolati B, Mancardi D, Giraudo E, Maione F, Cassoni P, Castellano I, Munaron L.

Sci Rep. 2016 Nov 11;6:35897. doi: 10.1038/srep35897. No abstract available.

39.

Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.

Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Med Oncol. 2016 Dec;33(12):137. Epub 2016 Nov 4.

PMID:
27815805
40.

Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.

Mellai M, Annovazzi L, Senetta R, Dell'Aglio C, Mazzucco M, Cassoni P, Schiffer D.

J Neurooncol. 2017 Jan;131(2):213-222. doi: 10.1007/s11060-016-2296-5. Epub 2016 Oct 28.

PMID:
27796734
41.

Corrigendum: Stromal contribution to the colorectal cancer transcriptome.

Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, Inghirami G, Trusolino L, Fekete Z, De Ridder M, Cassoni P, Storme G, Bertotti A, Medico E.

Nat Genet. 2016 Sep 28;48(10):1296. doi: 10.1038/ng1016-1296d. No abstract available.

PMID:
27681291
42.

Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor.

Pellerino A, Rudà R, Bertero L, Magistrello M, Franchino F, Cassoni P, Pasqualetti F, Pinessi L, Giangaspero F, Soffietti R.

J Neurosurg Sci. 2018 Apr;62(2):229-232. doi: 10.23736/S0390-5616.16.03804-2. Epub 2016 Sep 27. No abstract available.

PMID:
27676284
43.

Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling.

Avanzato D, Genova T, Fiorio Pla A, Bernardini M, Bianco S, Bussolati B, Mancardi D, Giraudo E, Maione F, Cassoni P, Castellano I, Munaron L.

Sci Rep. 2016 Sep 2;6:32602. doi: 10.1038/srep32602. Erratum in: Sci Rep. 2016 Nov 11;6:35897.

44.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S.

Oncogene. 2017 Mar 2;36(9):1200-1210. doi: 10.1038/onc.2016.283. Epub 2016 Aug 15.

PMID:
27524418
45.

Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.

Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Cassoni P, Arena V, Bustreo S, Faletti R, Rondi N, Morino M, Ricardi U.

Med Oncol. 2016 Jul;33(7):72. doi: 10.1007/s12032-016-0789-x. Epub 2016 Jun 8.

PMID:
27277756
46.

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.

Bustreo S, Osella-Abate S, Cassoni P, Donadio M, Airoldi M, Pedani F, Papotti M, Sapino A, Castellano I.

Breast Cancer Res Treat. 2016 Jun;157(2):363-371. doi: 10.1007/s10549-016-3817-9. Epub 2016 May 7.

47.

BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer.

Bartolini A, Cardaci S, Lamba S, Oddo D, Marchiò C, Cassoni P, Amoreo CA, Corti G, Testori A, Bussolino F, Pasqualini R, Arap W, Corà D, Di Nicolantonio F, Marchiò S.

Clin Cancer Res. 2016 Oct 1;22(19):4923-4933. Epub 2016 May 3.

48.

Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Anticancer Res. 2016 Apr;36(4):2027-32.

PMID:
27069197
49.

Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, Morino M, Racca P, Ricardi U.

Anticancer Res. 2016 Apr;36(4):1943-8.

PMID:
27069184
50.

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Duregon E, Bertero L, Pittaro A, Soffietti R, Rudà R, Trevisan M, Papotti M, Ventura L, Senetta R, Cassoni P.

Oncotarget. 2016 Apr 19;7(16):21190-8. doi: 10.18632/oncotarget.8498.

Supplemental Content

Loading ...
Support Center